BL21(DE3)pLysS vs. BL21(DE3) CodonPlus

CriteriaBL21(DE3)pLysSBL21(DE3) CodonPlusRemarks
Genetic BackgroundDerivative of E. coli BL21(DE3) containing the pLysS plasmidDerivative of BL21(DE3) engineered to carry additional tRNA genes for rare codonsBoth are BL21(DE3) derivatives, commonly used for T7 promoter-driven protein expression.
Key FeatureContains T7 lysozyme, which inhibits basal expression of T7 RNA polymeraseContains extra copies of tRNA genes (e.g., argU, ileY, leuW) for rare codonspLysS = tighter control; CodonPlus = improved translation of codon-biased genes.
Control of ExpressionTight control of expression, reduces leaky expression of toxic proteinsNo extra expression control but improves translation efficiency for codon-rich genespLysS is useful when protein toxicity is a concern.
Plasmid PresentYes – pLysS plasmid (chloramphenicol resistant)Yes – plasmid(s) for tRNA expression (e.g., chloramphenicol or streptomycin resistant)Antibiotic selection differs and should be considered during co-transformation.
Ideal ForExpression of toxic or tightly regulated proteinsExpression of eukaryotic or AT-rich genes with rare codons in E. coliCodonPlus is preferred for expressing genes from organisms with codon bias different from E. coli.
Expression EfficiencyModerate expression levels due to suppression by T7 lysozymeGenerally higher protein yield for codon-biased genesCodonPlus improves protein folding and solubility for such genes.
Induction SystemT7 promoter system induced with IPTGSame – T7 promoter induced with IPTGBoth use IPTG-inducible systems; control levels differ.
Toxic Protein ManagementReduces toxicity by limiting basal expressionNo control of basal expression – may cause issues with toxic proteinsUse pLysS for tight regulation when protein is lethal or inhibitory to host growth.
Compatibility with VectorsCompatible with T7-based expression vectors (e.g., pET series)Same – compatible with T7-based vectorsBoth support common T7-based systems.
ApplicationsToxic protein expression, basic protein expression requiring low backgroundHeterologous expression of genes with rare codons, including mammalian, parasite, or viral genesApplication choice depends on gene codon usage and protein toxicity.
Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *